miércoles, 8 de enero de 2025

Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-On Recombinant Peptide Products; Reopening of the Comment Period

https://www.federalregister.gov/documents/2024/12/31/2024-31365/evaluating-the-immunogenicity-risk-of-host-cell-proteins-in-follow-on-recombinant-peptide-products?utm_medium=email&utm_source=govdelivery

No hay comentarios: